D. Johansson

T cell-based therapies for atherosclerosis.

G. Hansson, D. Ketelhuth, A. Gisterå, 2013, Current pharmaceutical design.

Activation of the Regulatory T-Cell/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice

R. Baumgartner, G. Hansson, M. Mussbacher, 2018, Front. Immunol..

Acute Loss of Apolipoprotein E Triggers an Autoimmune Response That Accelerates Atherosclerosis

N. Maeda, G. Hansson, C. Binder, 2018, Arteriosclerosis, thrombosis, and vascular biology.

Atherosclerosis Susceptibility in Mice Is Independent of the V1 Immunoglobulin Heavy Chain Gene

D. Nilsson, G. Hansson, C. Binder, 2015, Arteriosclerosis, thrombosis, and vascular biology.

Immunotherapy With Tolerogenic Apolipoprotein B-100–Loaded Dendritic Cells Attenuates Atherosclerosis in Hypercholesterolemic Mice

G. Hansson, A. Hermansson, D. Ketelhuth, 2011, Circulation.

Attenuates Atherosclerosis in Hypercholesterolemic Mice Loaded Dendritic Cells − Immunotherapy With Tolerogenic Apolipoprotein B100

Xing-hua, G. Hansson, A. Hermansson, 2011 .